+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Breast Cancer Liquid Biopsy Testing Devices Market 2024-2028

  • PDF Icon

    Report

  • 145 Pages
  • June 2024
  • Region: Global
  • TechNavio
  • ID: 5606337
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The breast cancer liquid biopsy testing devices market is forecasted to grow by USD 1.16 billion during 2023-2028, accelerating at a CAGR of 31.34% during the forecast period. The report on the breast cancer liquid biopsy testing devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of breast cancer, increasing preference for non-invasive procedures, and rising number of new product launches and fda approvals.

The breast cancer liquid biopsy testing devices market is segmented as below:

By Type

  • CTCs and circulating nucleic acids
  • Extracellular vesicles

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the technological advances as one of the prime reasons driving the breast cancer liquid biopsy testing devices market growth during the next few years. Also, growing emphasis on breast cancer diagnosis and increasing focus on direct-to-customer marketing will lead to sizable demand in the market.

The report on the breast cancer liquid biopsy testing devices market covers the following areas:

  • Breast cancer liquid biopsy testing devices market sizing
  • Breast cancer liquid biopsy testing devices market forecast
  • Breast cancer liquid biopsy testing devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast cancer liquid biopsy testing devices market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Bio Rad Laboratories Inc., Cell Microsystems Inc., Exact Sciences Corp., F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Isogen Life Science BV, Mesa Laboratories Inc., Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., Novogene Co. Ltd., OncoDNA, Pfizer Inc., QIAGEN NV, SAGA Diagnostics AB, Sysmex Corp., and Thermo Fisher Scientific Inc. Also, the breast cancer liquid biopsy testing devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Breast Cancer Liquid Biopsy Testing Devices Market 2018 - 2022
Historic Market Size - Data Table on Global Breast Cancer Liquid Biopsy Testing Devices Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 CTCs and circulating nucleic acids - Market size and forecast 2023-2028
Chart on CTCs and circulating nucleic acids - Market size and forecast 2023-2028 ($ million)
Data Table on CTCs and circulating nucleic acids - Market size and forecast 2023-2028 ($ million)
Chart on CTCs and circulating nucleic acids - Year-over-year growth 2023-2028 (%)
Data Table on CTCs and circulating nucleic acids - Year-over-year growth 2023-2028 (%)
6.4 Extracellular vesicles - Market size and forecast 2023-2028
Chart on Extracellular vesicles - Market size and forecast 2023-2028 ($ million)
Data Table on Extracellular vesicles - Market size and forecast 2023-2028 ($ million)
Chart on Extracellular vesicles - Year-over-year growth 2023-2028 (%)
Data Table on Extracellular vesicles - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.10 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
8.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 A. Menarini Industrie Farmaceutiche Riunite Srl
A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
11.4 Exact Sciences Corp.
Exact Sciences Corp. - Overview
Exact Sciences Corp. - Product / Service
Exact Sciences Corp. - Key news
Exact Sciences Corp. - Key offerings
11.5 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.6 Illumina Inc.
Illumina Inc. - Overview
Illumina Inc. - Business segments
Illumina Inc. - Key news
Illumina Inc. - Key offerings
Illumina Inc. - Segment focus
11.7 Isogen Life Science BV
Isogen Life Science BV - Overview
Isogen Life Science BV - Product / Service
Isogen Life Science BV - Key offerings
11.8 Myriad Genetics Inc.
Myriad Genetics Inc. - Overview
Myriad Genetics Inc. - Product / Service
Myriad Genetics Inc. - Key news
Myriad Genetics Inc. - Key offerings
11.9 Natera Inc.
Natera Inc. - Overview
Natera Inc. - Product / Service
Natera Inc. - Key news
Natera Inc. - Key offerings
11.10 Novogene Co. Ltd.
Novogene Co. Ltd. - Overview
Novogene Co. Ltd. - Product / Service
Novogene Co. Ltd. - Key offerings
11.11 QIAGEN NV
QIAGEN NV - Overview
QIAGEN NV - Product / Service
QIAGEN NV - Key news
QIAGEN NV - Key offerings
11.12 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Breast Cancer Liquid Biopsy Testing Devices Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on CTCs and circulating nucleic acids - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on CTCs and circulating nucleic acids - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on CTCs and circulating nucleic acids - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on CTCs and circulating nucleic acids - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Extracellular vesicles - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Extracellular vesicles - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Extracellular vesicles - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Extracellular vesicles - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 47: Chart on Geographic comparison
Exhibits 48: Data Table on Geographic comparison
Exhibits 49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 85: Market opportunity By Geographical Landscape ($ million)
Exhibits 86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 87: Impact of drivers and challenges in 2023 and 2028
Exhibits 88: Overview on criticality of inputs and factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Companies covered
Exhibits 92: Matrix on companies position and classification
Exhibits 93: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
Exhibits 94: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
Exhibits 95: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
Exhibits 96: Exact Sciences Corp. - Overview
Exhibits 97: Exact Sciences Corp. - Product / Service
Exhibits 98: Exact Sciences Corp. - Key news
Exhibits 99: Exact Sciences Corp. - Key offerings
Exhibits 100: F. Hoffmann La Roche Ltd. - Overview
Exhibits 101: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 102: F. Hoffmann La Roche Ltd. - Key news
Exhibits 103: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 104: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 105: Illumina Inc. - Overview
Exhibits 106: Illumina Inc. - Business segments
Exhibits 107: Illumina Inc. - Key news
Exhibits 108: Illumina Inc. - Key offerings
Exhibits 109: Illumina Inc. - Segment focus
Exhibits 110: Isogen Life Science BV - Overview
Exhibits 111: Isogen Life Science BV - Product / Service
Exhibits 112: Isogen Life Science BV - Key offerings
Exhibits 113: Myriad Genetics Inc. - Overview
Exhibits 114: Myriad Genetics Inc. - Product / Service
Exhibits 115: Myriad Genetics Inc. - Key news
Exhibits 116: Myriad Genetics Inc. - Key offerings
Exhibits 117: Natera Inc. - Overview
Exhibits 118: Natera Inc. - Product / Service
Exhibits 119: Natera Inc. - Key news
Exhibits 120: Natera Inc. - Key offerings
Exhibits 121: Novogene Co. Ltd. - Overview
Exhibits 122: Novogene Co. Ltd. - Product / Service
Exhibits 123: Novogene Co. Ltd. - Key offerings
Exhibits 124: QIAGEN NV - Overview
Exhibits 125: QIAGEN NV - Product / Service
Exhibits 126: QIAGEN NV - Key news
Exhibits 127: QIAGEN NV - Key offerings
Exhibits 128: Thermo Fisher Scientific Inc. - Overview
Exhibits 129: Thermo Fisher Scientific Inc. - Business segments
Exhibits 130: Thermo Fisher Scientific Inc. - Key news
Exhibits 131: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 132: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 133: Inclusions checklist
Exhibits 134: Exclusions checklist
Exhibits 135: Currency conversion rates for US$
Exhibits 136: Research methodology
Exhibits 137: Information sources
Exhibits 138: Data validation
Exhibits 139: Validation techniques employed for market sizing
Exhibits 140: Data synthesis
Exhibits 141: 360 degree market analysis
Exhibits 142: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global breast cancer liquid biopsy testing devices market: A. Menarini Industrie Farmaceutiche Riunite Srl, Bio Rad Laboratories Inc., Cell Microsystems Inc., Exact Sciences Corp., F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Isogen Life Science BV, Mesa Laboratories Inc., Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., Novogene Co. Ltd., OncoDNA, Pfizer Inc., QIAGEN NV, SAGA Diagnostics AB, Sysmex Corp., and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advances."

According to the report, one of the major drivers for this market is the increasing prevalence of breast cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Bio Rad Laboratories Inc.
  • Cell Microsystems Inc.
  • Exact Sciences Corp.
  • F. Hoffmann La Roche Ltd.
  • Guardant Health Inc.
  • Illumina Inc.
  • Isogen Life Science BV
  • Mesa Laboratories Inc.
  • Myriad Genetics Inc.
  • Natera Inc.
  • NeoGenomics Laboratories Inc.
  • Novogene Co. Ltd.
  • OncoDNA
  • Pfizer Inc.
  • QIAGEN NV
  • SAGA Diagnostics AB
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.